Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Market Cap	188.07M
Revenue (ttm)	46.43M
Net Income (ttm)	-29.78M
Shares Out	80.37M
EPS (ttm)	-0.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,763
Average Volume	34,212
Open	2.250
Previous Close	2.300
Day's Range	2.250 - 2.340
52-Week Range	0.720 - 3.560
Beta	1.17
RSI	47.33
Earnings Date	Feb 19, 2026

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 30
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: BIOWKS

Financial Performance

In 2024, Bio-Works Technologies AB's revenue was 30.49 million, a decrease of -30.55% compared to the previous year's 43.90 million. Losses were -37.36 million, -34.25% less than in 2023.